PRISMA-based review of Pseudomonas spp. in microbial heavy-metal bioremediation: mechanisms and taxonomy
Abstract
Introduction: Bioremediation may be sustainable strategy for mitigating heavy-metal contamination in soils and related environmental matrices.
Methods: This paper, based on PRISMA 2020 guidelines analyzes 41 experimental studies published between 2022 and 2025, selected from Scopus, Web of Science, and PubMed, with the aim of comparing bacterial taxa, detoxification mechanisms, and remediation performance.
Results and discussion: Bacillus and Pseudomonas were the most frequently investigated genera, with Bacillus spp. achieving the highest removal efficiencies (>80%-90%) through biosorption and biomineralization mechanisms. On the other hand, Pseudomonas spp. showed a high functional and genetic versatility, combining efflux systems, enzymatic redox transformations, EPS production, and biofilm-mediated resilience, particularly in multi-metal and fluctuating environmental conditions. Median removal efficiencies was at least 70% in controlled laboratory assays, while it was 10%-25% in soil. Despite methodological heterogeneity, the evidence identifies Pseudomonas as a mechanistic benchmark genus rather than a universally superior biosorbent, owing to its extensive genomic characterization and broad detoxification repertoire. The review highlights the need for standardized experimental protocols, integration of multi-omics approaches, and field-scale validation to improve data comparability and to facilitate the translation of microbial bioremediation from laboratory studies to…
How strong is the evidence?
Evidence Hub reads this as a systematic review. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.